| Intensive lipid lowering with atorvastatin in patients with stable coronary disease JC LaRosa, SM Grundy, DD Waters, C Shear, P Barter, JC Fruchart, ... New England Journal of Medicine 352 (14), 1425-1435, 2005 | 4948 | 2005 |
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial GG Schwartz, AG Olsson, MD Ezekowitz, P Ganz, MF Oliver, D Waters, ... Jama 285 (13), 1711-1718, 2001 | 3893 | 2001 |
| Effects of torcetrapib in patients at high risk for coronary events PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ... New England journal of medicine 357 (21), 2109-2122, 2007 | 3733 | 2007 |
| 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice … RH Eckel, JM Jakicic, JD Ard, JM de Jesus, NH Miller, VS Hubbard, ... Circulation 129 (25_suppl_2), S76-S99, 2014 | 3639 | 2014 |
| American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus) A report of … GS Mintz, SE Nissen, WD Anderson, SR Bailey, R Erbel, PJ Fitzgerald, ... Journal of the American College of Cardiology 37 (5), 1478-1492, 2001 | 2604 | 2001 |
| Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) D Grady, D Herrington, V Bittner, R Blumenthal, M Davidson, M Hlatky, ... Jama 288 (1), 49-57, 2002 | 2428 | 2002 |
| Efficacy and safety of low-dose colchicine after myocardial infarction JC Tardif, S Kouz, DD Waters, OF Bertrand, R Diaz, AP Maggioni, FJ Pinto, ... New England journal of medicine 381 (26), 2497-2505, 2019 | 2211 | 2019 |
| Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1891 | 2011 |
| Aspirin, heparin, or both to treat acute unstable angina P Théroux, H Ouimet, J McCans, JG Latour, P Joly, G Lévy, E Pelletier, ... New England Journal of Medicine 319 (17), 1105-1111, 1988 | 1803 | 1988 |
| Effects of estrogen replacement on the progression of coronary-artery atherosclerosis DM Herrington, DM Reboussin, KB Brosnihan, PC Sharp, SA Shumaker, ... New England Journal of Medicine 343 (8), 522-529, 2000 | 1746 | 2000 |
| Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease B Pitt, D Waters, WV Brown, AJ van Boven, L Schwartz, LM Title, ... New England Journal of Medicine 341 (2), 70-76, 1999 | 1329* | 1999 |
| Prognostic value of exercise testing soon after myocardial infarction P Théroux, DD Waters, C Halphen, JC Debaisieux, HF Mizgala New England Journal of Medicine 301 (7), 341-345, 1979 | 914 | 1979 |
| Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials SM Boekholdt, GK Hovingh, S Mora, BJ Arsenault, P Amarenco, ... Journal of the American College of Cardiology 64 (5), 485-494, 2014 | 815 | 2014 |
| Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? T McLaughlin, G Reaven, F Abbasi, C Lamendola, M Saad, D Waters, ... The American journal of cardiology 96 (3), 399-404, 2005 | 768 | 2005 |
| Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study J Shepherd, P Barter, R Carmena, P Deedwania, JC Fruchart, S Haffner, ... Diabetes care 29 (6), 1220-1226, 2006 | 764 | 2006 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 741 | 2015 |
| Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection PY Hsue, JC Lo, A Franklin, AF Bolger, JN Martin, SG Deeks, DD Waters Circulation 109 (13), 1603-1608, 2004 | 732 | 2004 |
| Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial DD Waters, EL Alderman, J Hsia, BV Howard, FR Cobb, WJ Rogers, ... Jama 288 (19), 2432-2440, 2002 | 726 | 2002 |
| Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian … D Waters, L Higginson, P Gladstone, B Kimball, M Le May, SJ Boccuzzi, ... Circulation 89 (3), 959-968, 1994 | 710 | 1994 |
| Hyperlipidemia and coronary disease: correction of the increased thrombogenic potential with cholesterol reduction L Lacoste, JYT Lam, J Hung, G Letchacovski, CB Solymoss, D Waters Circulation 92 (11), 3172-3177, 1995 | 630 | 1995 |
Philip BarterUnivrsity of New South Wales Australia在 unsw.edu.au 的电子邮件经过验证
